LAMA5 and neoplasm: These observations strongly suggest that BCAM acts as a non‐signalling decoy receptor blocking the interaction of LAMA5 with β1‐containing integrins to diminish the attachment of single tumour cells to a matrix on the one hand, and to decrease the compactness of spheroids and enhance their dispersion at attachment sites on the other.